Prevalence of Symptomatic Gastroesophageal Reflux Disease in Czech Children (Czech GERDKids)
Recruiting now
Conditions studied: Gastro Esophageal Reflux
In brief
This study aims to determine the prevalence of symptomatic gastroesophageal reflux disease (GERD) in children aged 8-9 years and 12-13 years in the Czech Republic. Participants are recruited through schools and complete a web-based questionnaire assessing reflux-related symptoms. Children reporting pyrosis or regurgitation undergo a stepwise diagnostic evaluation that includes a standardized proton pump inhibitor (PPI) trial, upper endoscopy when indicated, and 24-hour pH-impedance monitoring for those with inconclusive findings. These procedures allow classification into confirmed GERD, reflux hypersensitivity, or functional pyrosis. All children undergoing diagnostic testing complete a validated quality-of-life questionnaire. The study will provide population-based prevalence estimates and evaluate symptom burden and potential risk factors associated with pediatric GERD.
Key facts
- Study ID
- NCT07482969
- Run by
- University Hospital, Motol
- People needed
- 1000
- Starts
- 2025-12-20
- Expected to finish
- 2028-12-30
- Last updated by the study team
- 2026-03-19
Who can join
Age: 8 and older, up to 13. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- age group of 8 - 9 years and 12 - 13 years
- school attendance ability
You may not qualify if…
- psychomotor impairment
Where it is running
- Motol University Hospital — Prague, Czechia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.